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Summary.-We observed the growth of 2 sublines of leukaemia L1210 in histo-
compatible DBA2 mice given 103 cells i.p. and studied the protective effect of
Corynebacterium parvum (CP). The growth of subline 1,1210 -M was unaffected by
pretreatment with CP or admixture with 105 peritoneal cells (PC) from CP-treated
mice. In contrast, the growth of subline L1210-C was inhibited; CP pretreatment
increased the proportion of long-term survivors (70°, vs 20%) and admixture with
CP-PC prolonged the survival time (59 days vs 49 days; P<0.05). In vitro experiments
indicated that Sublines M and C were equally sensitive to cytostasis by CP-PC, as
measured in a terminal labelling assay (>900o inhibition of proliferation). However,
subline C was much more sensitive to cytolysis (18h 1251UDR-release assay) by
CP-PC; percentage specific release from L1210-C was at least 90%o, whilst from
L1210-M it was generally <25%. The differential susceptibility of the 2 sublines to
cytolytic PC was maintained through 75 passages in culture. The effector cells were
considered to be macrophages, because they were adherent, phagocytic, and sensitive
to silica. Cytolysis was unrelated to endotoxin contamination, because it was not
inhibited by polymyxin B, and was inhibited by pre-incubating PC in culture medium
for 24 or 48 h before adding target cells.
Thus the relevance of nonspecific macrophage-mediated cytotoxicity in vitro to
tumour resistance in vivo may depend on the strength of the cytotoxic reaction.
A UNIQUE CHARACTERISTIC of macro-
phages is their ability to be rendered non-
specifically cytotoxic to tumour cells, a
phenomenon commonly referred to as
"activation" (Alexander, 1974; Hibbs,
1973). Macrophages can be activated by a
variety of stimuli, including lymphokines
(Fidler, 1974), double-stranded RNA,
endotoxin (Alexander & Evans, 1971),
synthetic polymers (Morahan & Kaplan,
1976) and micro-organisms such as BCG(
and Corynebacterium parvurn (CP) (Berd,
1978).
The cytotoxicity of activated macro-
phages was first demonstrated in growth
inhibition or "cytostasis" assays (Keller,
1973). Subsequently a number of authors
(Keller, 1976; Meltzer & Stevenson, 1977)
reported that activated macrophages
could also be cytolytic, i.e. kill tumour
cells directly, as measured by release of
pre-incorporated radioactive labels. While
it is often assumed that nonspecific cyto-
toxicity in vitro correlates with inhibition
of tumour growth in vivo, the correlation
has not been extensively tested, and some
authors have questioned it (e.g. Evans et
al., 1978).
We have studied 2 sublines of the
murine leukaemia LI 210, one that was
inhibited in vivo by CP or CP-activated
peritoneal cells (PC), and one that was not.
Susceptibility to inhibition in vivo was
associated with a much greater sensitivity
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to cytolysis by UP-activated peritoneal
macrophages in vitro.
MATERIALS AND METHODS
Mice. DBA2 mice, male or female, w%ere
obtained from the breeding colony of The
Institute for Cancer Research.
Tumnour. Leukaemia L1210 wras obtained
from Dr Bruce Smith as a tissue culture line.
We had developed 2 sublines for purposes
unrelated to this study: (1) L1210-C. passaged
twice as an ascites tumour in DBA2 mice and
then maintained in suspension culture; (2)
L1210-M, passaged weekly for 2 years as an
ascites tumour in DBA2 mice, and then
maintained in culture. Culture lines were
grown by biwreekly transfer in RPMI-1640
supplemented with 10w/, foetal calf serum,
L-glutamine, and penicillin and streptomycin
(RPMI-FCS) (Gibco, Grand Island, N.Y.).
The doubling time of L1210-C was 12 h and
of L1210-M 18 h.
L1210 is considered to be non-immuno-
genic (Skipper et al., 1964) and tumour-
specific antigens have not been demon-
strated.
Peritoneal cells (PC). Mice were injected
with either CP 0 5 mg i.p. (courtesy of
Burroughs Wellcome Co., Research Triangle
Park, N.C.) 5 days before, or 1 ml of 30o
thioglycollate broth 3 days before collection
ofPC. Mice ere killed by cervical dislocation
and the peritoneal cavity wvas lavaged with
8 ml RPMI wNith 10 u/ml heparin. About
5 x 106 PC were obtained per mouse treated
with CP, and about 4 x 106 per mouse treated
with thioglycollate. The PC were pelleted,
treated Nith Tris-buffered ammonium chlor-
ide to lyse erythrocytes, washed, suspended
in RPMI-FCS, and counted.
Cytotoxicity assays. Various numbers of
PC were added in a volume of 0-1 ml to the
wells of MicroTest 11 culture plates (Falcon
Plastics, Oxnard, Calif.) and incubated at
37°C in an atmosphrere of 500 CO2 for 1 h.
For the 1251UDR-release assay (cytolysis),
L1210 cells were labelled by incubating
5 x 106 cells with 1 jCi 125IUDR in 1 ml for
1 h. Then 104 1251UDR-labelled L1210 cells
in 041 ml RPMI-FCS were added to micro-
titre wells containing PC. Control wells con-
tained 104 labelled + 105 unlabelled tumour
cells. The microtitre plates were incubated
for 18 h at 37°C in 500 CO2. Then the plates
were centrifuged at 300 g for 15 min. A 0OIml
aliquot of supernatant fluid (total well
volume 0-2 ml) was removed from each well
and counted in a gamma counter. The per-
centage specific release of 125JUDR was cal-
culated as: X- S/T- 2S x 200, where X is the
mean ct/min of 3 aliquots from the test wells,
S is the mean ct/min of 6 aliquots from wells
containing tumour cells alone, and T is the
total ct/min originally added to each wAell.
Each PC sample was tested in triplicate, and
replicates varied < 10%. Both sublines in-
corporated 5000-10,000 ct/min/104 cells and
spontaneously released 1 0-1.5%/h.
For the terminal labelling assay (cytostasis)
104 unlabelled L1210 cells in 041 ml were
added to microtitre wells containing PC or
medium. The microtitre plates were incu-
bated at 37°C in 5% CO2 for 48 h. Then
125IUDR was added to each well in a final
concentration of 1 HtCi/ml in RPMI-FCS, and
the plates were incubated for 4 h. The con-
tens of the wells were harvested with an
automatic device and the nuclear material
embedded in filter-paper discs was counted
in a gamma counter. The percentage inhibi-
tion of 1251UDR incorporation was calculated
as: 100- (X/L) x 100, where X is the mean of
triplicate et/min incorporated by the mixture
of L1210 cells and PC, and L is the mean of
triplicate ct/min incorporated by L1210 cells
alone. PC alone did not incorporate signifi-
cantly. Normal PCwere not inhibitory. Micro-
titre wells were always examined by inverted
phase microscopy to verify that PC had in-
hibited cell proliferation as well as incorpora-
tion of isotope. In selected experiments, cell
counts were performed which correlated
exactly w-ith the results from terminal
labelling.
Treatment ofPC. Washing. PC were incu-
bated in microtitre wells for 1 h. Then the
medium was removed by a Pasteur pipette
connected to low-pressure suction and 0-2 ml
Hanks' balanced salt solution (Gibco) was
added. This process was repeated twice more
and then RPMI-FCS was added.
Additives-Silica (Santocel 68-courtesy
of Monsanto Industrial Chemicals, St Louis,
Mo) in various amounts was added 1 h before
the tumour cells. It did not cause destruction
or growth inhibition of L1210 cells. Poly-
myxin B was obtained from Burroughs
Wellcome Co.
Anti-Thy.l. This was culture supernatant
from a mouse hybridoma developed by Dr
Jonathan Sprent. It was used at a dilution of
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1:100, which lysed 99% ofDBA2 thymocytes
and 20% ofspleen cells. PC were incubated in
microtitre wells for 1 h. Then the medium
was removed and anti-Thy.1 was added.
After 1 h at 37°C, the PC were washed, and
diluted guinea-pig complement were added.
After 1 h at 37TC, the PC were again washed
and L1210 cells were added.
Fractionation of PC.-Ox 106 PC were
incubated in a 25cm2 culture flask at 37TC for
1 h. The flask was turned upright and the
medium with non-adherent cells was removed.
The cells removed were then incubated on
plastic a second time in the same manner and
designated "Non-Ad". Adherent cells were
washed thoroughly and then removed either
by scraping with a rubber policeman or addi-
tion of 10 mm EDTA (Ackerman & Douglas,
Survivors: 2/16
1978); these were designated "Ad". Of the
original PC, about 10% were recovered in the
Non-Ad and 20% in the Ad fraction.
Survival studie8.-L1210 cells were washed
twice and then suspended in Hanks' balanced
salt solution without serum. 103 L1210 cells
were injected i.p. into DBA2 mice that had
been pretreated with either CP or physio-
logical saline 5 days previously. In other ex-
periments mice were injected with mixtures
ofPC and L1210 cells inthefollowing manner:
PC obtained from CP-treated mice were pre-
pared as described for cytotoxicity assays,
pooled, and suspended at a concentration of
106/ml in RPMI without serum. Then 0-1 ml
PC (105 cells) was mixed with 1 ml L1210
cells (103 cells), and the mixture was immedi-
ately injected i.p. into normal DBA2 mice. In
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both types of experiment, the mice were
observed daily until death.
Assay of medium for endotoxin contamina-
tion.-The Limulus amaebocyte lysate (LAL)
assay was performed with a kit obtained from
MA Bioproducts, Bethesda, MD.
Statistics.-Comparisons of the results of
cytotoxicity assays were made by the t test;
the adaptation for non-independent samples
was used when appropriate (e.g. analysis of
the same sample before and after a certain
treatment). Survival experiments were
analysed by the Mann-Whitney U test.
RESULTS
Fffect ofCP on survival ofmice given L1210
We noted a marked difference in the
growth of the 2 L1210 sublines in DBA2
mice, and in the effect of CP on their
growth. 103 L1210-M cells i.p. killed
>9000 of mice, with a median survival
time of 18 days. Neither CP pre-treatment
(Fig. 1) nor admixture with 105 PC from
CP-treated mice (Fig. 2) significantly pro-
longed survival. In contrast, of mice given
103 L1210-C cells i.p., 30%o survived with-
out evidence of tumour for 90 days. The
survival time of mice that died varied
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FIG. 2. Effect of transfer of CP-activated
peritoneal cells on the survival of mice
challenged with L1210-M (A) and L1210-C
(B). DBA2 mice were injected i.p. with 103
L1210 cells alone (L1210+NT) or with a
mixture of 103 L1210 cells and 105 PC
obtained from mice injected with CP 5 days
previously (L1210+PC). Each point repre-
sents the survival time of one mouse. The
proportion of mice surviving without a
tumour is indicated at the top ofthe figure.
from one experiment to another, but was
in the range 50-70 days. Pretreatment
with CP significantly increased the pro-
portion of long-term survivors (7/10 vs
2/10; P< 0.05; Fig. 1). Mixing 103 L1210-C
with 105 CP-PC did not increase the pro-
portion of survivors, but did increase the
survival time of mice that died (59 days
vs 49 days, U=2, P<0 01).
Cytotoxicity ofPC to LI210 sublines
Because the most important biological
effect of CP is to activate macrophages
(Berd, 1978), we supposed that the 2
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+
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Fie. 2A.
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TABLE I. Susceptibility of two L1210 sublines (C and M) to cytostasis and cytolysis by
C. parvum-activated peritoneal cells (PC)
Cytolysis
(0% specific
1251UDR release)
Cxpt PC/TC* C Mt
A 25 86 2+ 2 9 12-3+3-6
12
B
C
6
25
25
92-4+1-3 404+1 1
89-6 + 1-8 24-2 + 1-8
Cytostasis
(0 inhibition)
C Al
95-1+1-3 97-2+1 2
31-0 + 14-9 45-5 + 18-3
0 0
98-8+0-4 99-6+0-2
95-6+0-4 90-8+2-1
Cytostasis was measured by a 481i terminal 125IUDR-labelling assay an(d cytolysis by an 18h125 IUDR
release assay; see Materials and Methods for details.
* PC/TC=ratio of peritoneal cells to tumour cells.
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FIG. 3. Cytolysis of L1210-C cells by un-
stimulated, thioglycollate-induced and CP-
activated peritoneal cells. Peritoneal cells
were obtained from mice pretreatedl with
C. parvum (CP), thioglycollate (Thlio), or
nothing (NT) and were tested for ability to
lyse 1251UDR-labelled L1210-C cells in an
18h assay. The ratio of PC to tumour cells
is as shown. Each point represents the
percentage specific release of 125IUDR
produced by a single sample of PC (pool of
2-4 mice) and the samples are from 3
experiments performed over 6 monthls.
L1210 sublines differed in their suscepti-
bility to the cytotoxicity of CP-induced
PC. As shown in Table I, L1210-M and
L1210-C were equally susceptible to the
cytostasis by CP-PC, i.e. their proliferative
capacity was inhibited by at least 9000.
However, LI210-C cells were much more
sensitive to cytloysis by CP-PC; percent-
age specific 1251UDR release from L1210-C
was usually about 90 0, whereas from
L1210-M it was never > 40%, and gener-
ally <25%. A 25:1 ratio of PC to tumour
cells was always sufficient for optimum
killing, and in some experiments ratios as
low as 6:1 were effective; increasing the
ration to 50:1 or 100 :1 did not increase the
cytolysis. The differential susceptibility of
the 2 sublines to PC cytolysis was main-
tained through 75 biweekly passages in
culture (Passage 2: L1210-C = 98-6 + 2*9,
L1210-M=16*1+3-2; Passage 75: C=
90*9+ 1-3 M=22-4+ 2.5).
Kinetic analysis indicated that cyto-
lysis was minimal after 6 h and complete
between 18 and 24 h. Prolonging the
incubation time to 48 h did not increase
the specific release of 1251UDR from the
less susceptible L1210-M cells. All the data
presented hereafter were from 18h assays.
PC stimulated by thioglycollate, and
unstimulated PC could both kill L1210-C
cells (Fig. 3). However, the degree of cyto-
lysis was variable, and PC:TC ratios of
100:1 were required for maximum killing.
Neither thioglycollate-induced nor normal
PC killed L1210-M cells.
A\ature of the effector cell
A series of experiments established that
the cytolytic PC were macrophages, not
T lymphocytes or natural killer (NK) cells.
The latter are found in abundance in the
E
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FIG. 4. Cytolysis of L1210-C cells by
adherent and non-adherent fractions of
activated peritoneal cells. CP-PC were left
unfractionated (UNFX), or incubated on
plastic flasks to isolate non-adherent (NON-
AD) and adherent (AD) fractions. (See
Materials and Methods for details.) They
were then tested forability to lyse 1251UDR-
labelled L1210-C cells. Each point repre-
sents the % specific release of 125IUDR
produced by a single sample of PC
(pool of 5-10 mice). Various ratios of PC
to L1210 cells were tested; only the ratio
producing the most lysis is represented.
For UNFX, ratios of 25:1 or 50:1 were
optimal, and for AD cells the optimal ratio
in each experiment was the same as for
UNFX cells. For NON-AD cells the optimal
ratio was 50:1 (killing was not increased at
the ratio of 100:1).
spleen and tend to disappear in aged mice
(Herberman et al., 1975). Spleen cells from
CP-treated mice were minimally cytolytic.
At spleen-cell: tumour-cell ratios of 50:1
or 100:1, no killing was observed, and at
even a ration of 200:1 mean 125IUDR re-
lease was only 13 6 + 3*2 /. Activated PC
from aged mice were as cytolytic as those
from young mice. In a representative ex-
periment, the cytolysis ofL1210-C cells by
PC from 6-week-old mice was compared
to that of 10-month-old mice; the per-
centage specific release 125IUDR was as
follows: young mice = 86-7 + 13-2, old mice
= 91'8 + 2-1 (mean + s.e. of 5 samples).
Fig. 4 shows the results of attempts to
isolate the effector PC after separation,
using their ability to adhere to plastic.
Unfractionated PC, of which 60-70%
phagocytized latex particles, were highly
cytolytic. Non-Ad PC, of which 10-15%
phagocytized latex particles, were only
slightly or non-cytolytic. Six of 9 samples
of Ad cells (90% phagocytic) were cyto-
lytic to about the same degree as unfrac-
tionated PC. Thus, cytolytic cells were re-
covered in the strongly adherent, phago-
cytic fraction ofPC.
Further evidence that the effector cells
were macrophages was their sensitivity to
silica, which is selectively toxic for macro-
phages (Allison et al., 1966). The addition
of 20 ,-g of silica to the microtitre wells
decreased cytolysis from 70-7 + 5.7% to
2-6+ 2.2%.
Finally, we investigated the effect of
washing and treatment with monoclonal
anti-Thy.1 antibody. It was not possible
to treat PC in suspension with anti-Thy.1
becauseincubation inplastic orsiliconized-
glass tubes at 37°C caused most cells to
adhere to the surface. Therefore, we
TABLE II.-Effect of washing and anti-
Thy.1 serum on cytolysis of L1210-C
cells
Percentage
specific
release
Expt Treatment of PC 125IUDR P
A NT 74-3+1-9 < <005
W 685+3 6}
B NT 86-8+33
W 73-3+3.9f<1
C NT 95*2±+2-8 <001
W 75-2+7 3 < NS
W+C' 71-7+6-2 <0.01 W+anti-Thy. 1+C' 59 6 + 7-9f _
D NT 89-2±l-7 <001
W+C' 54-7+2-3 <0.05 W+anti-Thy. I+C' 49.4+ 19 f
25 x l04 CP-PC were allowed to adhere in micro-
titre wells for 2 h and then washed or washed and
treated with monoclonal anti-Thy.1 as described in
Materials and Methods. Then 104 125IUDR-labelled
L1210-C cells were added. Mean+s.e. of 5 samples
(each of 3 mice) in Expts A, B and D and of 9
samples (each of one mouse) in Expt C.
NT =no treatment, W=wash only, C' =guinea-
pig complement.
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allowed PC to adhere to microtitre wells
for 1 h and then washed the wells vigor-
ously to remove non-adherent and loosely-
adherent PC. We then added anti-Thy.1,
followed by guinea-pig complement,
medium followed by complement, or
medium followed by medium. As shown in
Table II, washing alone diminished cyto-
lysis, though the diminution was quite
variable between experiments. Treatment
with anti-Thy. I plus complement in addi-
tion to washing diminished cytolysis
somewhat compared to washing alone,
but wA,ashed, anti-Thy.1-treated PC
effected 1251UDR release from >50% of
L1210-C cells.
We concluded that the cytolytic effector
cells were macrophages, but could not rule
out the possible role of T lymphocytes as
augmenting cells.
Role of endotoxin in inacrophage-mediated
cytolysis
The medium utsed for measuring cyto-
lysis (RPMI + 10% FCS) was assayed
repeatedly for endotoxin by the LAL
technique, and the result was always
2 ng/ml. This was entirely due to endo-
toxin contamination of FCS, since un-
supplemented RPMI was always negative
(< l. ng/ml). Weinberg et al. (1978) re-
ported that although 1 ng/ml endotoxin
was sometimes sufficient to induce acti-
vated macrophages to become cytolytic,
lower concentrations were ineffective.
Therefore we reasoned that if endotoxin
played an important role in our system
lowering the endotoxin concentration to
0 2 ng/ml by performing the assay in 1%
instead of 10% FCS might abrogate the
cytolytic activity. Lowering the FCS con-
centration produced no change in macro-
phage-mediated cytolysis of L1210-C (per-
centage 125JUDR release: 10% FCS =
81-8 + 2-9; 100 FCS = 82.9 + 1.9). Moreover,
the addition of polymyxin B, an inhibitor
of endotoxin (Weinberg et al., 1978) to
medium containing either 100% or 10 FCS
didnotaffectcytolytic activity (percentage
1251UDR release: 10 %FCS= 82-9+ 1-9; 10
FCS + 25 ,tg/ml polymyxin B = 79.4 + 3.5).
Finally, we reasoned that if macro-
phages were rendered cytolytic by endo-
toxin contamination of the medium, pre-
incubating macrophages in the contamin-
ated medium 24 or 48 h before adding
tumour cells should enhance cytolysis
(Doe & Henson, 1978). On the contrary,
pre-incubating activated macrophages de-
creased their ability to kill L1210-C cells
(no pre-incubation = 84 3 + 1 30o; 24h pre-
incubation= 433 + 3 6%; 48h pre-incuba-
tion = 25-0 + 2-2%).
DISCUSSION
The tumour system described here pro-
vided an interesting opportunity to
address the question of the significance of
nonspecific macrophage-mediated cyto-
toxicity. We studied 2 cultured sublines
of leukaemia L1210. C. parvum-activated
peritonal cells inhibited the proliferation
of the 2 sublines equally in a cytostasis
assay, but were much more strongly cyto-
lytic in an 1251UDR-release assay for the
subline L1210-C, than for L1210-M. The
different susceptibility to cytolysis were
stable through 75 or more biweekly trans-
fers in culture.
The data clearly show that the cyto-
lytic effector cells were macrophages; they
were silica-sensitive and recoverable in a
fraction enriched in adherent, phagocytic
cells. The participation of natural killer
cells was unlikely, because of: (a) un-
diminished cytolysis by PC from aged
mice, and (b) minimal cytolytic capability
of non-adherent PC or unfractionated
spleen cells (Herberman et al., 1975).
However, we could not eliminate the
possibility that the macrophage-mediated
cytolysis was augmented by a non-
adherent cell, especially a T lymphocyte,
because washing the macrophages and
washing plus anti-Thy.1 treatment regu-
larly (though to a variable degree) dimin-
ished cytolysis.
It is unlikely that cytolysis was medi-
ated by endotoxin contamination of the
culture medium. Lowering the endotoxin
concentration to 0-2 ng/ml and/or adding
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polymyxin B, which blocks the action of
endotoxin (Weinberg et al., 1978), did not
abrogate cytolysis. Moreover, pre-incu-
bating the macrophages in medium for 24
or 48 h decreased cytolysis. If the little
endotoxin in our medium was responsible
for rendering macrophages cytolytic, pre-
incubation should have had the opposite
effect (Doe & Henson, 1978).
The in vivo experiments showed that the
high-cytolysis subline L1210-C was slow-
growing and its growth was further in-
hibited by pretreatment with CP or by
adding CP-activated PC. The low-cyto-
lysis subline M was fast-growing, and its
growth was inhibited by neither CP nor
CP-PC.
We believe that we have observed non-
specific, macrophage-mediated cytolysis,
and have demonstrated one aspect of the
relationship of cytotoxicity in vitro to
anti-tumour effects in vivo. Evans et al.
(1978) have proposed that activated
macrophages "may express a spectrum of
cytotoxic reactivity from transient growth
inhibition to irreversible lysis". It seems
likely that cytotoxic reactions on the
stronger end ofthe spectrum (e.g. the high
degree of cytolysis with the L1210-C sub-
line) are associated with significant re-
sistance to tumours in vivo; on the other
hand, reactions on the weaker end of the
spectrum (e.g. cytostasis and the low
degree of cytolysis with the L1210-M sub-
line) may not be associated with in vivo
resistance. It might be argued that the in
vivo protection from LI210-C conferred by
CP and CP-PC was only coincidentally
associated with a high degree of in vitro
cytolysis, and was actually a consequence
ofthe slower growth ofthis subline, which
could produce a higher LD50. However,
there is little or no evidence in the litera-
ture to support such an explanation and,
in fact, it has been shown that activated
macrophages can confer protection from
tumours that are rapidly growing with
very low LD50s as well as those that are
slow-growing (Peters et al., 1977).
We cannot rule out the possibility that
our system was measuring antigen-
specific as well as nonspecific cytolysis.
The L1210-C subline could have been
rendered weakly immunogenic as a result
of the acquisition of a viral antigen (Svet-
Moldavsky et al., 1970) and this could
explain its slower growth rate in DBA2
mice. C. parvum could then have acted as
an adjuvant, the end result being macro-
phages capable of killing L1210-C cells in
vitro and conferring protection from them
in vivo. The experiments suggesting the
role of T lymphocytes as augmenting cells
in the cytolytic reaction are consistent
with this possibility.
Our observations do not conclusively
decide whether nonspecifically cytotoxic
macrophages play a significant role in re-
sistance to malignant tumours. However,
they do suggest that in considering the
biological relevance of these macrophages,
the quantitation of their cytotoxic poten-
tial in vitro may be more important than
previously realized.
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